Two enantiomers of 2-hydroxyglutarate (2HG), L (L2HG) and D (D2HG), are metabolites of unknown function in mammalian cells that were initially associated with separate and rare inborn errors of metabolism resulting in increased urinary excretion of 2HG linked to neurological deficits in children (Chalmers ., 1980; Duran ., 1980; Kranendijk ., 2012). More recently, investigators have shown that D2HG is produced by mutant isocitrate dehydrogenase enzymes associated with a variety of human malignancies, such as acute myeloid leukemia, glioblastoma multiforme, and cholangiocarcinoma (Cairns and Mak, 2013; Dang ., 2009; Ward ., 2010). By contrast, we and others have shown that L2HG accumulates in response to cellular reductive stressors like hypoxia, activation of hypoxia inducible factors, and mitochondrial electron transport chain defects (Oldham ., 2015; Reinecke ., 2011; Intlekofer ., 2015; Mullen ., 2015). Each enantiomer is produced and metabolized in independent biochemical pathways in reactions catalyzed by separate enzymes and utilizing different cofactors with presumably different consequences for cellular metabolism (Kranendijk ., 2012). Therefore, as research into the roles of D2HG and L2HG in human metabolism continues, it becomes increasingly important for investigators to consider each enantiomer independently (Struys, 2013). Several methods for quantification of biochemically relevant enantiomers in general have been developed and typically include enzymatic assays using enzymes specific for one enantiomeric species or the other, the use of chiral chromatography medium to facilitate chromatographic separation of enantiomers prior to spectroscopy, or the use of chiral derivatization reagents to convert a mixture of enantiomers to diastereomers with differing physical and chemical properties facilitating their chromatographic separation. In this protocol, we report the adaptation of a previously published derivatization method using diacetyl-l-tartaric anhydride (DATAN) for the quantification of 2HG enantiomers (Figure 1) (Oldham ., 2015; Struys ., 2004).
Cell Rep. 2014 Jun 12;7(5):1679-90
[PMID:
24857658]
Cancer Cell. 2010 Mar 16;17 (3):225-34
[PMID:
20171147]
Cell Metab. 2015 Aug 4;22(2):291-303
[PMID:
26212716]
J Inherit Metab Dis. 1980;3(1):11-5
[PMID:
6774165]
J Inherit Metab Dis. 1980;3(4):109-12
[PMID:
6787330]
Clin Chem. 2004 Aug;50(8):1391-5
[PMID:
15166110]
Nat Protoc. 2012 Apr 12;7(5):872-81
[PMID:
22498707]
Nature. 2009 Dec 10;462(7274):739-44
[PMID:
19935646]
Sci Rep. 2015 Oct 13;5:15217
[PMID:
26458332]
Cell Metab. 2015 Aug 4;22(2):304-11
[PMID:
26212717]
Cancer Discov. 2013 Jul;3(7):730-41
[PMID:
23796461]
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4939
[PMID:
24319093]
J Inherit Metab Dis. 2012 Jul;35(4):571-87
[PMID:
22391998]